UPPI logo bug color2016c (002).jpg
Cardinal Health Is Sued by a Whistleblower for Cheating Government Program Intended to Help Small Businesses through “Rent-A-Vet” Scheme
August 25, 2020 15:52 ET | UPPI, LLC
SUWANEE, Ga., Aug. 25, 2020 (GLOBE NEWSWIRE) -- UPPI, a group of small business nuclear pharmacies that specialize in radiopharmaceutical products, has filed a False Claims Act lawsuit against health...
image
Rafarma to be Acquired by R. & D. Biocogency Laboratories Inc.
August 04, 2020 09:15 ET | RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency...
artms_logo_rgb_Jan2017 150dpi.png
ARTMS and Telix Pharmaceuticals Announce Manufacturing Collaboration
May 06, 2020 09:00 ET | ARTMS Products Inc.
VANCOUVER, British Columbia and MELBOURNE, Australia, May 06, 2020 (GLOBE NEWSWIRE) -- ARTMS Products Inc. (ARTMS), a global leader in the development of novel technologies enabling the production...
Curium Announces App
Curium Announces Approval of Pulmotech™ MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration
March 24, 2020 02:00 ET | Curium
St. Louis, MO, March 24, 2020 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration (FDA) has approved Pulmotech MAA.  When labeled to technetium Tc 99m, Pulmotech...
Jubilant Pharma.jpg
Jubilant Receives Favorable Rulings from the U.S. Patent Office Invalidating Bracco Rubidium-Infusion-System Patents
February 17, 2020 08:00 ET | Jubilant Pharma
YARDLEY, Pa., Feb. 17, 2020 (GLOBE NEWSWIRE) -- On February 7, 2020, Jubilant DraxImage Inc., and certain of its affiliates (“Jubilant”) were informed by the U.S. Patent Office that it agreed with...
Jubilant Pharma.jpg
Jubilant Radiopharma Receives Approval from Health Canada for Drax Exametazime®
January 27, 2020 16:05 ET | Jubilant Pharma
YARDLEY, Pa., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Jubilant Radiopharma, the Radiopharmaceutical Division of Jubilant Pharma Ltd, announced today that the company received approval from Health Canada...
Jubilant Pharma.jpg
Jubilant Receives Favorable Ruling from the U.S. Courts for RUBY-FILL®
December 11, 2019 16:45 ET | Jubilant Pharma
YARDLEY, Pa., Dec. 11, 2019 (GLOBE NEWSWIRE) -- On December 2, 2019, Jubilant DraxImage Inc. and certain of its affiliates (“Jubilant”) received notice of the favorable decision of the U.S....
Curium Announces Rev
Curium Announces Revised Pricing for Technescan MAG3TM
September 04, 2019 08:30 ET | Curium
St. Louis, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it is implementing a new pricing model for Technescan MAG3.  Curium is phasing out its pay per dose sales model, in which...
20170406 Telix Logo.png
Telix Pharmaceuticals e Grupo RPH firmam Contrato de Manufatura e Distribuição para a LATAM
July 02, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Austrália e PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- A Telix Pharmaceuticals Limited (ASX.TLX) ( “Telix”, a “Empresa”), uma empresa biofarmacêutica de fase clínica...
20170406 Telix Logo.png
Telix Pharmaceuticals y Grupo RPH firman acuerdo de fabricación y distribución en América Latina 
July 02, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia y PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, la “Compañía”), una compañía biofarmacéutica en fase-clínica,...